BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

GPC-100, a CXCR4 Inhibitor, Moves Toward AML Trials Following Promising Preclinical and Phase 1 Data; Phase 2 in Multiple Myeloma Ongoing

Exicure, Inc. shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning f...

April 14, 2025 | News

Novartis Commits $23B to U.S. Expansion, Bringing 100% of Key Drug Production Onshore

Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities With new manuf...

April 11, 2025 | News

Halozyme and argenx Secure FDA Nod for VYVGART® Hytrulo Prefilled Syringe for Self-Injection

Halozyme Therapeutics, Inc. announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART® Hytrulo prefilled syri...

April 11, 2025 | News

Nona Biosciences Partners with Atossa Therapeutics to Advance Next-Generation Antibody Therapies for Breast Cancer

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), ranging from target validation and antibody ...

April 11, 2025 | News

CAS and Cleveland Clinic Join Forces to Accelerate Drug Discovery and Brain Health Research

CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic ...

April 08, 2025 | News

I Peace Brings Personalized iPS Cell and Longevity Therapies to the U.S.

– I Peace, Inc., a global pioneer in induced pluripotent stem cell (iPSC) technology, proudly announces the U.S. launch of its groundbreaking persona...

April 07, 2025 | News

Bayer Seeks U.S. Supreme Court Intervention in Missouri Roundup™ Case Amid Nationwide Labeling Disputes

Bayer – through its indirect subsidiary Monsanto – filed its petition for a writ of certiorari with the U.S. Supreme Court in the&nbs...

April 07, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU Approved in EU for Earlier Treatment of HER2 Low and Ultralow Breast Cancer

Based on DESTINY-Breast06 phase 3 trial results which showed ENHERTU demonstrated superiority versus chemotherapy with a median progression-free surviv...

April 04, 2025 | News

Cytiva Introduces MabSelect SuRe 70 & PrismA X to Boost Cost-Efficient mAb Purification

MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva's expanded resin portfolio wil...

April 04, 2025 | News

Senhwa’s CX-4945 Shows Promising Disease Control and Durability in Refractory Basal Cell Carcinoma

Basal Cell Carcinoma CSR Highlights CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Res...

April 03, 2025 | News

TCI Biotech Elevates CDMO+ Services with US-Based Glass Bottling for Liquid Supplements

TCI Biotech (TCI Co., Ltd.), a CDMO+ organization specializing in health and wellness products, is spotlighting its comprehensive US-based glass bottling s...

April 03, 2025 | News

LBB Specialties Partners with Kerry Group to Distribute Sheffield™ Pharmaceutical Lactose in the U.S.

LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce a new par...

April 03, 2025 | News

Thermo Fisher Scientific Launches Krios 5 Cryo-TEM, Setting New Standard in Atomic-Resolution Imaging

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generati...

April 03, 2025 | News

SHL Medical Launches $220M Autoinjector Facility in South Carolina to Boost US Production and Global Supply

SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-o...

April 02, 2025 | News

Stay Connected